CD1E
Basic information
Region (hg38): 1:158353696-158357553
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD1E gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 2 |
Variants in CD1E
This is a list of pathogenic ClinVar variants found in the CD1E region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-158354383-A-G | not specified | Uncertain significance (Sep 13, 2023) | ||
1-158354383-A-T | not specified | Uncertain significance (Sep 09, 2024) | ||
1-158354430-C-T | not specified | Uncertain significance (Nov 12, 2024) | ||
1-158354431-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
1-158354472-C-T | not specified | Uncertain significance (Apr 06, 2022) | ||
1-158354541-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
1-158354623-A-G | Benign (Apr 10, 2018) | |||
1-158354647-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
1-158354655-G-A | not specified | Likely benign (Nov 11, 2024) | ||
1-158355323-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
1-158355372-A-G | not specified | Uncertain significance (Dec 20, 2021) | ||
1-158355434-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
1-158355528-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
1-158355534-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
1-158355851-G-C | not specified | Uncertain significance (Sep 25, 2024) | ||
1-158355899-C-T | not specified | Uncertain significance (Sep 20, 2024) | ||
1-158355919-G-A | not specified | Uncertain significance (Jun 04, 2024) | ||
1-158355959-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
1-158355970-G-C | not specified | Uncertain significance (Nov 30, 2022) | ||
1-158355976-G-A | not specified | Likely benign (Oct 22, 2021) | ||
1-158355993-C-T | Benign (Apr 10, 2018) | |||
1-158356010-G-A | not specified | Uncertain significance (Jul 25, 2024) | ||
1-158356058-G-T | not specified | Uncertain significance (Oct 16, 2024) | ||
1-158356540-T-A | not specified | Uncertain significance (Nov 14, 2024) | ||
1-158356750-C-T | not specified | Uncertain significance (Sep 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD1E | protein_coding | protein_coding | ENST00000368167 | 6 | 4090 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.26e-18 | 0.000667 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.110 | 224 | 219 | 1.02 | 0.0000121 | 2509 |
Missense in Polyphen | 48 | 43.944 | 1.0923 | 555 | ||
Synonymous | -1.02 | 93 | 81.3 | 1.14 | 0.00000390 | 776 |
Loss of Function | -1.00 | 24 | 19.3 | 1.25 | 0.00000106 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000561 | 0.000549 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000831 | 0.000816 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000240 | 0.000237 |
Middle Eastern | 0.000831 | 0.000816 |
South Asian | 0.000491 | 0.000490 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: T-cell surface glycoprotein CD1e, soluble binds diacetylated lipids, including phosphatidyl inositides and diacylated sulfoglycolipids, and is required for the presentation of glycolipid antigens on the cell surface. The membrane- associated form is not active. {ECO:0000269|PubMed:10948205, ECO:0000269|PubMed:16311334, ECO:0000269|PubMed:21788486}.;
- Pathway
- Tight junction - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0974
Intolerance Scores
- loftool
- 0.994
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.57
Haploinsufficiency Scores
- pHI
- 0.172
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00276
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- positive regulation of T cell mediated cytotoxicity;adaptive immune response;immune response;antigen processing and presentation, endogenous lipid antigen via MHC class Ib;antigen processing and presentation, exogenous lipid antigen via MHC class Ib
- Cellular component
- Golgi membrane;extracellular space;early endosome;late endosome;plasma membrane;integral component of plasma membrane;external side of plasma membrane;lysosomal lumen
- Molecular function
- endogenous lipid antigen binding;exogenous lipid antigen binding;lipopeptide binding